Senti Biosciences is trading 6.9% lower at $0.15 after closing at $0.17 on October 30; no fresh company-specific reason for the after-hours decline was identified.
- Its regular-session close fell 23.92%, following several volatile sessions.
- The latest identified company news concerned a board resignation and CVR record date, announced earlier in the week.
- Major U.S. indexes were lower and technology-sector pressure was reported on October 30; this may have contributed, but no direct company-specific cause was confirmed.